Menopausal weight gain is not simply about willpower or calories. Learn how GLP-1 medicines may help some women — and why muscle, protein, HRT, testosterone and insulin resistance still matter. Why menopause changes the weight-loss conversation Many women reach midlife and feel as if the rules have suddenly changed. The same diet that once worked no longer works. Weight appears around the middle, cravings become harder to control, sleep deteriorates, brain fog creeps in, energy drops. And, all too often, the advice they receive is painfully simplistic and (some would argue) verging on misogynist. “Eat less and move more.” That advice is entirely wrong. For our view on why Calorie Counting is the wrong approach click here: Menopause is not just the end of periods. It is a major hormonal and metabolic transition. Falling oestrogen affects body fat distribution, insulin sensitivity, muscle mass, sleep, mood, vascular health, bone density, urogenital health and appetite regulation. That’s why GLP-1 medicines such as semaglutide and tirzepatide have attracted so much attention. They can reduce appetite, improve blood glucose control and help people lose significant amounts of weight. But in menopausal women, the question is not simply: “Will this help me lose weight?” the right question is: “Can this help improve metabolic health without making muscle, nutrition, hormones or long-term resilience worse?” That is absolutely the conversation we should be having. Menopausal weight gain is metabolic, not moral One of the most common experiences during perimenopause and menopause is weight gain around the abdomen. This is not just cosmetic because increased visceral fat is strongly associated with insulin resistance, fatty liver, raised blood pressure, inflammation and cardiovascular risk. The frustrating part is that most women have not really changed their behaviour. They may be eating similarly, drinking similarly and exercising similarly (even exercising more and eating less perhaps) but their biology has changed.